Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients—A BioCAPTURE Registry Study

BACKGROUND: Psoriasis is a common inflammatory disease in any age group, but also in older patients (≥ 65 years of age). Since older patients are often excluded from clinical trials, limited data specifically on this growing population are available, e.g. regarding the safety and performance of biol...

Descripción completa

Detalles Bibliográficos
Autores principales: ter Haar, E. L. M., Thomas, S. E., van den Reek, J. M. P. A., Otero, M. E., Njoo, M. D., Ossenkoppele, P. M., Kop, E. N., Dodemont, S. R. P., Körver, J. E. M., Kuijpers, A. L. A., Lindhout, R. J., Tupker, R. A., Mommers, J. M., Berends, M. A. M., Koetsier, M. I. A., de Bruin-Weller, M. S., Visch, M. B., Arnold, W. P., van Lümig, P. P. M., Kleinpenning, M. M., Lubeek, S. F. K., de Jong, E. M. G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300332/
https://www.ncbi.nlm.nih.gov/pubmed/35859228
http://dx.doi.org/10.1007/s40266-022-00961-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300332/
https://www.ncbi.nlm.nih.gov/pubmed/35859228
http://dx.doi.org/10.1007/s40266-022-00961-y

Ejemplares similares